Stay updated on Cabometyx + Avelumab in mRCC Clinical Trial
Sign up to get notified when there's something new on the Cabometyx + Avelumab in mRCC Clinical Trial page.

Latest updates to the Cabometyx + Avelumab in mRCC Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added to the page, and the previous government operating status notice was removed. The core study information remains unchanged.SummaryDifference0.5%

- Check41 days agoChange DetectedAdded a government-funding status notice and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check48 days agoChange DetectedAdded a Show glossary option, updated labeling from 'Last Update Submitted that met QC Criteria' to 'Last Update Submitted that Met QC Criteria,' and introduced a 'No FEAR Act Data' notice along with a Revision: v3.4.0 tag. These are UI and metadata changes and do not alter core study content, eligibility, results, or planned procedures.SummaryDifference0.2%

- Check63 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedUtah has been added as a study location under Locations. The page revision now shows v3.3.3, and the HHS Vulnerability Disclosure link in the footer was removed.SummaryDifference0.2%

Stay in the know with updates to Cabometyx + Avelumab in mRCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabometyx + Avelumab in mRCC Clinical Trial page.